JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways
Stem Cell
Wnt/β-catenin

Wnt/β-catenin

A3011 CHIR-99021 (CT99021)
2 Citation

Target: GSK-3

Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive

≥23.27 mg/mL
A3413 FH535

Summary: Wnt/B-catenin inhibitor

≥36.1 mg/mL
A3512 IWP-2
2 Citation

Summary: Wnt production inhibitor,PORCN inhibitor

≥23.35 mg/mL
A3785 Salinomycin

Target: Antibiotic

Summary: Polyether ionophore antibiotic;anti-cancer
A4529 JW 55

Summary: PARP domain inhibitor

insoluble in H2O; ≥19.25 mg/mL
A8213 KY 02111

Summary: WNT signaling inhibitor

insoluble in H2O; ≥18.85 mg/mL
A8217 ICG 001
1 Citation

Summary: Wnt/β-catenin pathway inhibitor

≥27.43 mg/mL
A1877 XAV-939
1 Citation

Target: TNKS

Summary: Tankyrase 1/2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
A8396 CHIR-99021 (CT99021) HCl

Target: GSK-3

Summary: GSK-3α/β inhibitor

≥25.1 mg/mL
A8600 Tankyrase Inhibitors (TNKS) 22

Summary: Tankyrase inhibitor